267 related articles for article (PubMed ID: 20620169)
1. Safety and immunogenicity of single dose of tetanus-diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007.
Bitragunta S; Murhekar MV; Chakravarti A; Verma V; Namjoshi GS; Parekh SS; Sharma HJ; Kumar BK; Gupte MD
Vaccine; 2010 Aug; 28(37):5934-8. PubMed ID: 20620169
[TBL] [Abstract][Full Text] [Related]
2. Immunization coverage and immunity to diphtheria and tetanus among children in Hyderabad, India.
Murhekar MV; Bitragunta S; Hutin Y; Ckakravarty A; Sharma HJ; Gupte MD
J Infect; 2009 Mar; 58(3):191-6. PubMed ID: 19195713
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of the new reduced-dose tetanus-diphtheria vaccine in healthy Korean adolescents: A comparative active control, double-blind, randomized, multicenter phase III study.
Han SB; Rhim JW; Shin HJ; Kim SY; Kim JH; Kim HH; Lee KY; Kim HM; Choi YY; Ma SH; Kim CS; Kim DH; Ahn DH; Kang JH
J Microbiol Immunol Infect; 2017 Apr; 50(2):207-213. PubMed ID: 26055693
[TBL] [Abstract][Full Text] [Related]
4. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
[TBL] [Abstract][Full Text] [Related]
5. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
6. Baseline immunity to diphtheria and immunologic response after booster vaccination with reduced diphtheria and tetanus toxoid vaccine in Thai health care workers.
Wiboonchutikul S; Manosuthi W; Sangsajja C; Thientong V; Likanonsakul S; Srisopha S; Termvises P; Rujitip J; Loiusirirotchanakul S; Puthavathana P
Am J Infect Control; 2014 Jul; 42(7):e81-3. PubMed ID: 24751139
[TBL] [Abstract][Full Text] [Related]
7. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD
Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379
[TBL] [Abstract][Full Text] [Related]
8. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
Chan SH; Tan PT; Han HH; Bock HL
Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
[TBL] [Abstract][Full Text] [Related]
10. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D
Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980
[TBL] [Abstract][Full Text] [Related]
11. [Diphtheria immunity in school beginners and after reimmunization with d-vaccine].
Naumann P; Weber HG
Dtsch Med Wochenschr; 1992 Aug; 117(35):1308-12. PubMed ID: 1505351
[TBL] [Abstract][Full Text] [Related]
12. Immunity against diphtheria among children and adults in Izmir, Turkey.
Kurugöl Z; Midyat L; Türkoğlu E; Işler A
Vaccine; 2011 Jun; 29(26):4341-4. PubMed ID: 21510994
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and Safety of a Newly Developed Tetanus-Diphtheria Toxoid (Td) in Healthy Korean Adolescents: a Multi-center, Randomized, Double-blind, Active-Controlled Phase 3 Trial.
Choi UY; Kim KH; Lee J; Eun BW; Kim HM; Lee KY; Kim DH; Ma SH; Lee J; Kim JH
J Korean Med Sci; 2021 Dec; 36(49):e313. PubMed ID: 34931494
[TBL] [Abstract][Full Text] [Related]
14. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
15. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
[TBL] [Abstract][Full Text] [Related]
16. Seroprotection against diphtheria and tetanus among Russian and Norwegian teenagers.
Danilova E; Shiryayev A; Kristoffersen EK; Sjursen H
APMIS; 2006 Jun; 114(6):453-7. PubMed ID: 16856968
[TBL] [Abstract][Full Text] [Related]
17. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
18. [Immunogenicity and safety of a tetanus-diphtheria vaccine (adult type): clinical trial in adults].
Gil A; Dal-Ré R; González A; Lasheras L; Aguilar L; del Rey J
Med Clin (Barc); 1995 Feb; 104(4):126-9. PubMed ID: 7898155
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
20. Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants.
Puumalainen T; Dagan R; Wuorimaa T; Zeta-Capeding R; Lucero M; Ollgren J; Käyhty H; Nohynek H
Pediatr Infect Dis J; 2003 Feb; 22(2):141-9. PubMed ID: 12586978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
